
1. Emerg Infect Dis. 2005 Sep;11(9):1461-3.

Multidrug-resistant tuberculosis detection, Latvia.

Skenders G(1), Fry AM, Prokopovica I, Greckoseja S, Broka L, Metchock B, Holtz
TH, Wells CD, Leimane V.

Author information: 
(1)State Centre of Tuberculosis and Lung Diseases, Riga, Latvia.

To improve multidrug-resistant tuberculosis (MDR-TB) detection, we successfully
introduced the rpoB gene mutation line probe assay into the national laboratory
in Latvia, a country with epidemic MDR-TB. The assay detected rifampin resistance
with 91% sensitivity and 96% specificity within 1 to 5 days (vs. 12-47 days for
BACTEC).

DOI: 10.3201/eid1109.041236 
PMCID: PMC3310615
PMID: 16229783  [Indexed for MEDLINE]

